- $99.43bn
- $118.21bn
- £31.38bn
- 92
- 66
- 99
- 98
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Issuance of Notes
AnnouncementRCS - Osler Diagnostics Ld - Osler Diagnostics Announces a Company Update
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Appointments to Designate Haleon Board
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK Annual Report 2021 on Form 20-F
AnnouncementREG - GlaxoSmithKline PLC - GSK publishes Annual Report 2021
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Daprodustat application accepted for review by EMA
AnnouncementREG - GlaxoSmithKline PLC - GSK introduces Haleon to investors
AnnouncementREG - GlaxoSmithKline PLC - GSK RSV maternal vaccine candidate further update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
Announcement